Swine flu has reached Europe


Spain's Health Ministry confirmed Europe's first case of swine flu on Monday. In the next 24 hours dozens of suspected cases cropped up all over Europe. On Tuesday, suspected cases were reported in Germany, the Czech Republic, Italy, Greece, Ireland, Denmark and Sweden.
The EU has called for an extraordinary meeting of health ministers and issued a travel advisory against non-essential trips to areas where the virus has surfaced. There's no European action plan against a pandemic. Each is taking measures on a national level, which are overseen by ECDC.
The virus is a novel human H1N1 influenza variant with genomic elements of human, avian and porcine flu viruses, which apparently is able to be transmitted from human to human but up to now has not been identified in pigs, acording to the Centers for Disease Control (CDC) in Atlanta.
So far the only "swine flu" deaths recorded have been in Mexico, where 7 people were confirmed to have died from the disease. The United States has recorded the second highest rate of infection, but no deaths.
Acting CDC director Richard Besser rejected a warning from EU Health Commissioner Androulla Vassiliou that appeared to call on Europeans to avoid travel to the United States and Mexico, calling it "quite premature." US virologists recommended not to panic but to analyse the virus’ target group and the number of confirmed cases.
Reports from the CDC indicate that the virus is susceptible to the usual neuraminidase blockers Oseltamivir (Tamiflu, Roche) and Zanamivir (Relenza, GlaxoSmithKline).
On Wednesday morning Swiss Roche AG confirmed that it is working closely with the World Health Organization (WHO) and governments around the world to make the oral antiviral medication Tamiflu available to patients in need following the increased reports of outbreaks of swine flu. Revenues with the flu therapy , which is active against this new swine flu virus A(H1N1), dropped significantly last year as there were few cases of avian flu.



Madrid – Nowhere in the world, is the concentration of GM-sceptics higher than it is in Europe, but their reign is not supreme. On the south-western tip of the continent, Spain stands out for its “science-based agricultural...



Seville – Genetrix S.L. and the Botín Foundation will channel a 6m over the next three years into the new company Axontherapix SL. The public-private partnership will seek to develop an effective therapy for Parkinson’s Disease....



Pamplona – With a record-setting Biospain this year, the Spanish biotech industry has underpinned its role as a premier player in the sector in southern Europe. More than 1,400 business representatives flocked to Pamplona, where...



Bilbao – Spanish Progenika Biopharma S.A has gained the green light for sale of its LPLchip in Europe. The DNA chip, which has achieved the CE mark, detects approximately 120 mutations in the lipoprotein lipase (LPL) gene and...



Madrid – Responding to the current debate surrounding the reactome array investigation, Manuel Ferrer from the Institute of Catalysis and Petrochemistry in Madrid told EuroBiotechNews his team would “clarify all the scientific...



Madrid – When Chinese Premier Wen Jiabao met his Spanish colleague Jose Luis Rodriguez Zapatero on August 31st, he talked about the Mediterranean country’s role as an important economic partner for China, and said cooperation...



Madrid/Braunschweig - Spanish and German scientists who last year reported a groundbreaking technology that is able to identify the whole set of biochemical reactions in bacteria or cells, together with the enzymes involved, have...



Barcelona – While the cash-strapped Spanish government is being stripped of its AAA grade investment rating, one of the giants of the country’s life science industry is on a spending spree. Grifols, a producer of plasma protein...



Barcelona/Nantes – Biomarker-specialist TcLand Expression in Nantes has found an ally in the Vall d’Hebron University Hospital Research Institute (HVIR) in Barcelona. The French company and the Spanish clinic will work together...

Displaying results 21 to 30 out of 181

< Previous 21-30 Next >

© 2007-2016 BIOCOM


Current issue

All issues

Product of the week


Stock list

All quotes


  • DIAMYD MEDICAL -B- (S)5.70 SEK21.54%
  • QIAGEN NV (D)23.48 EUR12.29%
  • MOBERG PHARMA (S)44.10 SEK10.25%


  • MOLOGEN (D)1.81 EUR-11.71%
  • NICOX (F)9.62 EUR-8.29%
  • SAREUM HOLDINGS (UK)0.72 GBP-6.49%


  • PROTHENA PLC (IE)55.05 USD57.5%
  • DIAMYD MEDICAL -B- (S)5.70 SEK37.3%
  • VERNALIS (UK)44.50 GBP31.9%


  • MOLOGEN (D)1.81 EUR-38.4%
  • SANTHERA (CH)56.20 CHF-26.9%
  • EVOCUTIS (UK)0.04 GBP-20.0%


  • KARO BIO (S)33.00 SEK1962.5%
  • NICOX (F)9.62 EUR425.7%
  • SAREUM HOLDINGS (UK)0.72 GBP213.0%


  • BB BIOTECH (D)44.83 EUR-84.6%
  • EVOCUTIS (UK)0.04 GBP-76.5%

No liability assumed, Date: 29.07.2016


All Events